Ticker
TCRTCompany Name
ALAUNOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 5.27M | $ 0 | $ 0 | $ 0 | 0% |
3/31/2025 | $ 4.62M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2024 | $ 2.35M | $ 0 | $ 0 | $ 0 | 0% |
9/30/2024 | $ 3.74M | $ 0 | $ 0 | $ 0 | 0% |
6/30/2024 | $ 3.88M | $ 0 | $ 0 | $ 0 | 0% |
3/31/2024 | $ 19.05M | $ 0 | $ -11.98M | $ 0 | 62.87% |
12/31/2023 | $ 28.02M | $ 92K | $ -18.23M | $ 0 | 64.73% |
9/30/2023 | $ 17.88M | $ 14.82M | $ -24.48M | $ 0 | 54.05% |
6/30/2023 | $ 94.71M | $ 14.79M | $ -26.56M | $ 0 | 12.43% |
3/31/2023 | $ 149.16M | $ 14.79M | $ -14.58M | $ 0 | -0.14% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ALAUNOS THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 104.75M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 518.58M ]
(=) Shareholder Yield [ -20.2% ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |